Search Prime Grants

W81XWH2211055

Project Grant

Overview

Grant Description
SERUM BIOMARKERS FOR CLASSIFYING INJURY SEVERITY AND PREDICTING OUTCOME AFTER ACUTE SPINAL CORD INJURY
Awardee
The University Of British Columbia
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Canada
Geographic Scope
Foreign
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $1,879,124 to $0.
The University Of British Columbia was awarded Project Grant W81XWH2211055 from Defense Health Agency in September 2022 with work to be completed primarily in Canada. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 5/10/23

Period of Performance
9/30/22
Start Date
9/29/25
End Date
52.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Transaction History

Modifications to W81XWH2211055

Additional Detail

Award ID FAIN
W81XWH2211055
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Nonprofit Without 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
SJR5MQHSLWT6
Awardee CAGE
1C035
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $1,879,124 100%
Modified: 5/10/23